Cargando…

Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases

Detalles Bibliográficos
Autores principales: Richette, Pascal, Allez, Matthieu, Descamps, Vincent, Perray, Lucas, Pilet, Simon, Latourte, Augustin, Maravic, Milka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/
https://www.ncbi.nlm.nih.gov/pubmed/34314887
http://dx.doi.org/10.1016/j.jbspin.2021.105253
_version_ 1783727540316143616
author Richette, Pascal
Allez, Matthieu
Descamps, Vincent
Perray, Lucas
Pilet, Simon
Latourte, Augustin
Maravic, Milka
author_facet Richette, Pascal
Allez, Matthieu
Descamps, Vincent
Perray, Lucas
Pilet, Simon
Latourte, Augustin
Maravic, Milka
author_sort Richette, Pascal
collection PubMed
description
format Online
Article
Text
id pubmed-8305295
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Masson SAS on behalf of Société française de rhumatologie.
record_format MEDLINE/PubMed
spelling pubmed-83052952021-07-26 Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases Richette, Pascal Allez, Matthieu Descamps, Vincent Perray, Lucas Pilet, Simon Latourte, Augustin Maravic, Milka Joint Bone Spine Letter to the Editor Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. 2022-01 2021-07-24 /pmc/articles/PMC8305295/ /pubmed/34314887 http://dx.doi.org/10.1016/j.jbspin.2021.105253 Text en © 2021 Published by Elsevier Masson SAS on behalf of Société française de rhumatologie. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Richette, Pascal
Allez, Matthieu
Descamps, Vincent
Perray, Lucas
Pilet, Simon
Latourte, Augustin
Maravic, Milka
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title_full Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title_fullStr Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title_full_unstemmed Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title_short Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
title_sort impact of covid-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/
https://www.ncbi.nlm.nih.gov/pubmed/34314887
http://dx.doi.org/10.1016/j.jbspin.2021.105253
work_keys_str_mv AT richettepascal impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT allezmatthieu impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT descampsvincent impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT perraylucas impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT piletsimon impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT latourteaugustin impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases
AT maravicmilka impactofcovid19oninitiationofbiologictherapyprescriptionsforchronicinflammatorydiseases